|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 61 | 2018 | Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries | BIELEN, Rob; Stumo, Samya R.; Halford, Rachel; Werling, Klara; Reic, Tatjana; Stoever, Heino; ROBAEYS, Geert; Lazarus, Jeffrey V. | Journal Contribution | A1 |
| 62 | 2017 | Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe | Marshall, A. D.; Nielsen, S.; Cunningham, E. B.; Aghemo, A.; Alho, H.; Backmund, M.; Bruggmann, P.; Dalgard, O.; Flisiak, R.; Foster, G.; Gheorghe, L.; Goldberg, D.; Goulis, I.; Hickman, M.; Hoffmann, P.; Jancoriene, L.; Jarcuska, P.; Kaberg, M.; Makara, M.; Maimets, M.; Marinho, R.; Maticic, M.; Norris, S.; Olafsson, S.; Ovrehus, A.; Pawlotsky, J. -M.; Pocock, J.; ROBAEYS, Geert; Roncero, C.; Simonova, M.; Sperl, J.; Tait, M.; Tolmane, I.; Tomaselli, S.; van der Valk, M.; Vince, A.; Dore, G. J.; Lazarus, J. V.; Grebely, J. | Journal Contribution | M |
| 63 | 2017 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van der Merwe, S.; Pirenne, J.; Nevens, F. | Journal Contribution | M |
| 64 | 2017 | The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without pegylated interferon: a Belgian experience | BIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Francque, S.; Verlinden, W.; Brixko, C.; Decaestecker, J.; De Galocsy, C.; Janssens, F.; Cool, M.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, Geert | Journal Contribution | M |
| 65 | 2017 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van Der Merwe, S.; Pirenne, J. | Conference Material | C2 |
| 66 | 2017 | The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience | BIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, Geert | Conference Material | C2 |
| 67 | 2017 | The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience. | BIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; Wuyckens, K.; Nevens, F.; ROBAEYS, Geert | Conference Material | C2 |
| 68 | 2017 | The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience | BIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Vanwolleghem, T.; Verlinden, W.; Brixco, C.; Decaestecker, J.; de Galocsy, C.; Janssens, F.; Van Overbeke, L.; Van Steenkiste, C.; D'Heygere, F.; Cool, M.; Wuyckens, K.; Nevens, F.; ROBAEYS, Geert | Journal Contribution | A1 |
| 69 | 2017 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van Der Merwe, S.; Pirenne, J.; Nevens, F. | Conference Material | C2 |
| 70 | 2017 | Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study | Cunningham, Evan B.; Hajarizadeh, Behzad; Dalgard, Olav; Amin, Janaki; Hellard, Margaret; Foster, Graham R.; Bruggmann, Philip; Conway, Brian; Backmund, Markus; ROBAEYS, Geert; Swan, Tracy; Marks, Philippa S.; Quiene, Sophie; Applegate, Tanya L.; Weltman, Martin; Shaw, David; Dunlop, Adrian; Bruneau, Julie; Midgard, Havard; Bourgeois, Stefan; Thurnheer, Maria Christine; Dore, Gregory J.; Grebely, Jason | Journal Contribution | A1 |
| 71 | 2017 | Cessation of Nucleos(t)ide Analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients | Van Hees, Stijn; Bourgeois, Stefan; Van Vlierberghe, Hans; Serste, Thomas; Francque, Sven; Michielsen, Peter P.; Dirk, Sprengers; Reynaert, Hendrik; Henrion, Jean; Dastis, Sergio Negrin; Delwaide, Jean; Lasser, Luc; Decaestecker, Jochen; Orient, Hans; Janssens, Filip; ROBAEYS, Geert; Colle, Isabelle; Starkel, Peter; Moreno, Christophe; Nevens, Frederik; Vanwolleghem, Thomas | Journal Contribution | M |
| 72 | 2017 | Belgian experience with direct acting antivirals in people who inject drugs | BIELEN, Rob; Moreno, Christophe; Van Vlierberghe, Hans; Bourgeois, Stefan; Mulkay, Jean-Pierre; Vanwolleghem, Thomas; Verlinden, Wim; Brixko, Christian; Decaestecker, Jochen; De Galocsy, Chantal; Janssens, Filip; Cool, Mike; Van Overbeke, Lode; Van Steenkiste, Christophe; D'heygere, Francois; COOLS, Wilfried; Nevens, Frederik; ROBAEYS, Geert | Journal Contribution | A1 |
| 73 | 2017 | Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study | Grebely, Jason; Dalgard, Olav; Cunningham, Evan B.; Hajarizadeh, Behzad; Foster, Graham R.; Bruggmann, Philip; Conway, Brian; Backmund, Markus; ROBAEYS, Geert; Swan, Tracy; Amin, Janaki; Marks, Philippa S.; Quiene, Sophie; Applegate, Tanya L.; Weltman, Martin; Shaw, David; Dunlop, Adrian; Hellard, Margaret; Bruneau, Julie; Midgard, Havard; Bourgeois, Stefan; Staehelin, Cornelia; Dore, Gregory J. | Journal Contribution | A1 |
| 74 | 2017 | Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study | Midgard, Havard; Hajarizadeh, Behzad; Cunningham, Evan B.; Conway, Brian; Backmund, Markus; Bruggmann, Philip; Bruneau, Julie; Bourgeois, Stefan; Dunlop, Adrian; Foster, Graham R.; Hellard, Margaret; ROBAEYS, Geert; Thurnheer, Maria C.; Weltman, Martin; Amin, Janaki; Marks, Philippa S.; Quiene, Sophie; Dore, Gregory J.; Dalgard, Olav; Grebely, Jason | Journal Contribution | A1 |
| 75 | 2017 | Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse | Lamoury, Francois M. J.; Soker, Angelica; Martinez, Danica; Hajarizadeh, Behzad; Cunningham, Evan B.; Cunningham, Philip; Bruggmann, Philip; Foster, Graham R.; Dalgard, Olav; Backmund, Markus; Conway, Brian; ROBAEYS, Geert; Swan, Tracy; Cloherty, Gavin; Marks, Pip; Grebely, Jason; Dore, Gregory J.; Applegate, Tanya L. | Journal Contribution | A1 |
| 76 | 2017 | Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs | Grebely, Jason; Bruneau, Julie; Lazarus, Jeffrey V.; Dalgard, Olav; Bruggmann, Philip; Treloar, Carla; Hickman, Matthew; Hellard, Margaret; Roberts, Teri; Crooks, Levinia; Midgard, Havard; Larney, Sarah; Degenhardt, Louisa; Alho, Hannu; Byrne, Jude; Dillon, John F.; Feld, Jordan J.; Foster, Graham; Goldberg, David; Lloyd, Andrew R.; Reimer, Jens; ROBAEYS, Geert; Torrens, Marta; Wright, Nat; Maremmani, Icro; Norton, Brianna L.; Litwin, Alain H.; Dore, Gregory J. | Journal Contribution | A1 |
| 77 | 2016 | Global genotype distribution of hepatitis C viral infection among people who inject drugs | BIELEN, Rob; ROBAEYS, Geert; Darush, Ghezel Azar; Razavi, Homie; Nevens, Frederik | Journal Contribution | M |
| 78 | 2016 | Global genotype distribution of hepatitis C viral infection among people who inject drugs | BIELEN, Rob; ROBAEYS, Geert; Darush, Ghezel Azar; Razavi, Homie; Nevens, Frederik | Journal Contribution | A1 |
| 79 | 2016 | Global genotype distribution of hepatitis C viral infection among people who inject drugs | BIELEN, Rob; ROBAEYS, Geert; Darush, Ghezel Azar; Razavi, Homie; Nevens, Frederik | Conference Material | C2 |
| 80 | 2016 | Pilot Study: Combining Formal and Peer Education with FibroScan to Increase HCV Screening and Treatment in Persons who use Drugs | ARAIN, Amber; De Sousa, Jessica; Corten, Kirsten; Verrando, Rita; THIJS, Herbert; Mathei, Catharina; Buntinx, Frank; ROBAEYS, Geert | Journal Contribution | A1 |
Loading...
5
0
5
0
false